Enhanced photodyamic therapy via photosensitizer-loaded nanoparticles for cancer treatment

被引：23

作者：

Jeon G. ^{[1
]}

Ko Y.T. ^{[1
]}

机构：

[1] College of Pharmacy, Gachon Institute of Pharmaceutical Sciences, Gachon University, 191 Hambakmoe-ro, Yeonsu-gu, Incheon

来源：

Journal of Pharmaceutical Investigation | 2019年 / 49卷 / 1期

关键词：

Drug delivery; Nanoparticles; Photodynamic therapy; Photosensitizer; Tumor;

D O I：

10.1007/s40005-017-0363-3

中图分类号：

学科分类号：

摘要：

Cancer is one of the most challenging human disease to cure, and has high rate to death. The current major cancer treatments include surgery, chemotherapy and radiation therapy. However, these treatments have a lot of obstacles that included low efficacy, mortality and severe aftereffects. Photodynamic therapy is developing cancer therapy that photosensitizer (PS) transfers energy from light to molecular oxygen damaged to generate reactive oxygen species (ROS). These reactions occur in the immediate locale of the light-absorbing PS. Almost of PSs have obstacle to adjust in human body system. Nanoparticle systems (NS) were used to overcome problems like drug solubility, delivery and low efficacy. Nanoparticles loaded anticancer drug, small molecule drug, biomedicine and PSs. In this review, we summarize the studies that have confirmed the nanoparticle systems loading PSs which are Phthalocyanine 4, Photofrin ® , Temoporfin, Levulan ® and Foscan ® cancer therapy and discuss the future direction for the this novel therapy. © 2017, The Korean Society of Pharmaceutical Sciences and Technology.

引用

页码：1 / 8

页数：7

共 46 条

[1]

Abd-Elgaliel W.R., Cruz-Monserrate Z., Wang H., Et al., Pancreatic cancer-associated Cathepsin E as a drug activator, J Control Release, 167, 3, pp. 221-227, (2013)

[2]

Akimoto J., Photodynamic therapy for malignant brain tumors, Neurol Med Chir (Tokyo), 56, 4, pp. 151-157, (2016)

[3]

Bolzinger M.-A., Briancon S., Pelletier J., Et al., Penetration of drugs through skin, a complex rate-controlling membrane, Curr Opin Colloid Interface Sci, 17, 3, pp. 156-165, (2012)

[4]

Brezaniova I., Hruby M., Kralova J., Et al., Temoporfin-loaded 1-tetradecanol-based thermoresponsive solid lipid nanoparticles for photodynamic therapy, J Control Release, 241, pp. 34-44, (2016)

[5]

Calixto G.M., Bernegossi J., de Freitas L.M., Et al., Nanotechnology-Based Drug Delivery Systems for Photodynamic Therapy of Cancer: A Review, Molecules, 21, 3, (2016)

[6]

Chan M.H., Pan Y.T., Lee I.J., Et al., Minimizing the heat effect of photodynamic therapy based on inorganic nanocomposites mediated by 808 nm near-infrared light, Small, 13, 21, (2017)

[7]

Choi J.H., Lee Y.J., Kim D., Image-guided nanomedicine for cancer, J Pharm Invest, 47, 1, pp. 51-64, (2016)

[8]

Delmas T., Piraux H., Couffin A.C., Texier I., Vinet F., Poulin P., Cates M.E., Bibette J., How to prepare and stabilize very small nanoemulsions, Int J Pharm, 27, 5, pp. 1683-1692, (2011)

[9]

Di Corato R., Bealle G., Kolosnjaj-Tabi J., Espinosa A., Clement O., Silva A.K., Menager C., Wilhelm C., Combining magnetic hyperthermia and photodynamic therapy for tumor ablation with photoresponsive magnetic liposomes, Am Chem Soc, 9, (2014)

[10]

Dixit S., Novak T., Miller K., Et al., Transferrin receptor-targeted theranostic gold nanoparticles for photosensitizer delivery in brain tumors, Nanoscale, 7, 5, pp. 1782-1790, (2015)

← 1 2 3 4 5 →